IL-6, IL-8, and IL-10 Are Associated with Hyperferritinemia in Rapidly Progressive Interstitial Lung Disease with Polymyositis/Dermatomyositis

IL-6, IL-8, and IL-10 Are Associated with Hyperferritinemia in Rapidly Progressive Interstitial Lung Disease with Polymyositis/Dermatomyositis

Objective. Hyperferritinemia is frequently accompanied by rapidly progressive (RP) interstitial lung disease (ILD) with polymyositis (PM)/dermatomyositis (DM). To clarify the mechanism of RP-ILD with hyperferritinemia, we investigated the associations between serum ferritin levels and various cytoki...

Full description

Bibliographic Details
Main Authors:	Hidenaga Kawasumi, Takahisa Gono, Yasushi Kawaguchi, Hirotaka Kaneko, Yasuhiro Katsumata, Masanori Hanaoka, Sayuri Kataoka, Hisashi Yamanaka
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2014/815245

Similar Items

Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Physical Dysfunction after Treatment in Polymyositis and Dermatomyositis: An Observational Study of Physical Dysfunction with Myositis in Japan
by: Hidenaga Kawasumi, et al.
Published: (2016-01-01)

Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies
by: Hidenaga Kawasumi, et al.
Published: (2015-01-01)

Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies
by: Hidenaga Kawasumi, et al.
Published: (2015-07-01)

Association between a C8orf13-BLK polymorphism and polymyositis/dermatomyositis in the Japanese population: an additive effect with STAT4 on disease susceptibility.
by: Tomoko Sugiura, et al.
Published: (2014-01-01)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
by: Yumiko Sugiyama, et al.
Published: (2018-01-01)

Coadministration of Cyclosporin a with Prednisolone in Acute Interstitial Pneumonia Complicating Polymyositis/Dermatomyositis
by: Yasuhiro Shimojima, et al.
Published: (2012-01-01)

Coadministration of Cyclosporin A with Prednisolone in Acute Interstitial Pneumonia Complicating Polymyositis/Dermatomyositis
by: Yasuhiro Shimojima, et al.
Published: (2012-03-01)

Electrocardiographic changes in dermatomyositis and polymyositis
by: Leticia Miranda Alle Deveza, et al.
Published: (2016-04-01)

Interstitial Lung Disease with ANCA-associated Vasculitis
by: Yasuhiro Katsumata, et al.
Published: (2015-01-01)

Interstitial Lung Disease with ANCA-associated Vasculitis
by: Yasuhiro Katsumata, et al.
Published: (2015-09-01)

Respiratory disorders in patients with polymyositis/dermatomyositis
by: Olga Alekseyevna Antelava, et al.
Published: (2014-03-01)

Polymyositis and dermatomyositis – challenges in diagnosis and management
by: Shu-Han Yang, et al.
Published: (2019-12-01)

Polymyositis, Dermatomyositis, and Statins: A Review
by: Mauro Turrin
Published: (2018-12-01)

Polymyositis and dermatomyositis: Disease spectrum and classification
by: Siba P Raychaudhuri, et al.
Published: (2012-01-01)

Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan
by: Furuya, T., et al.
Published: (2022)

Development of comorbid infection in patients with polymyositis/dermatomyositis
by: O A Antelava, et al.
Published: (2009-06-01)

Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis.
by: Li Zhang, et al.
Published: (2016-01-01)

Polymyositis-Dermatomyositis and Interstitial Lung Disease in Pregnant Woman Successfully Treated with Cyclosporine and Tapered Steroid Therapy
by: Saito Mayu, et al.
Published: (2019-01-01)

HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis /Dermatomyositis with Interstitial Lung Disease.
by: Xiaoming Shu, et al.
Published: (2016-01-01)

MiR-146a Regulates Inflammatory Infiltration by Macrophages in Polymyositis/Dermatomyositis by Targeting TRAF6 and Affecting IL-17/ICAM-1 Pathway
by: Yuanqin Yin, et al.
Published: (2016-11-01)

Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis
by: Takuya Hirai, et al.
Published: (2018-01-01)

Diagnosis of dermatomyositis and polymyositis: a study of 102 cases
by: SCOLA ROSANA HERMINIA, et al.
Published: (2000-01-01)

The clinical application of tumor markers in the screening of malignancies and interstitial lung disease of dermatomyositis/polymyositis patients: A retrospective study
by: Chong Hong Lim, et al.
Published: (2018-06-01)

Positive Association between ANKRD55 Polymorphism 7731626 and Dermatomyositis/Polymyositis with Interstitial Lung Disease in Chinese Han Population
by: Liubing Li, et al.
Published: (2017-01-01)

Anterior segment parameters associated with extramuscular manifestations in polymyositis and dermatomyositis
by: Zoltan Griger, et al.
Published: (2020-09-01)

Dermatomyositis and polymyositis in breast cancer patients: a case reports
by: I P Ganshina, et al.
Published: (2018-03-01)

Review paper Polymyositis and dermatomyositis as a risk of developing cancer
by: Michał Jakubaszek, et al.
Published: (2015-05-01)

Acute interstitial nephritis in association with polymyositis
by: Das J, et al.
Published: (2008-01-01)

ANTISYNTHETASE SYNDROME IS THE MOST SEVERE SUBTYPE OF POLYMYOSITIS/DERMATOMYOSITIS:DESCRIPTION OF CASES
by: Olga Alekseyevna Antelava, et al.
Published: (2009-12-01)

Upregulation of Interleukin 21 and Interleukin 21 Receptor in Patients with Dermatomyositis and Polymyositis
by: Tao Liu, et al.
Published: (2017-01-01)

Epilepsy as a Comorbidity in Polymyositis and Dermatomyositis—A Cross-Sectional Study
by: Ella Nissan, et al.
Published: (2021-04-01)

Hypomyopathic Dermatomyositis with Refractory Dermatitis Treated by Low-dose IL-2
by: Miao Miao, et al.
Published: (2020-07-01)

Efficiency of Therapeutic Plasma-Exchange in Acute Interstitial Lung Disease, Associated With Polymyositis/Dermatomyositis Resistant to Glucocorticoids and Immunosuppressive Drugs: A Retrospective Study
by: Yaogui Ning, et al.
Published: (2019-11-01)

Increased risk of venous thromboembolism associated with polymyositis and dermatomyositis: a meta-analysis
by: Li Y, et al.
Published: (2018-01-01)

Meta-Analysis of Polymyositis and Dermatomyositis Microarray Data Reveals Novel Genetic Biomarkers
by: Jaeseung Song, et al.
Published: (2019-10-01)

Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis
by: Gilmara Franco da Cunha, et al.
Published: (2013-05-01)

Malignancy in a retrospective cohort of 17 patients with Dermatomyositis or Polymyositis in southern Tunisia
by: Sellami Khadija, et al.
Published: (2018-12-01)

Quantitative texture analysis of T2- weighted MR images in polymyositis and dermatomyositis patients
by: Xie, Yuan
Published: (2017)

IL-1RN VNTR Polymorphism in Adult Dermatomyositis and Systemic Lupus Erythematosus
by: Zornitsa Kamenarska, et al.
Published: (2014-01-01)

Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis
by: Akiko Tochimoto, et al.
Published: (2016-03-01)